RALEIGH – Medtech services firm Veranex – launched a year ago – continues to be on a binge of acquisitions to expand its information technology services portfolio as well as its physical footprint.
Today the company – backed by global investment firm Summit Partners – announced the acquisition of several medical device consultancy firms in Sweden. Financial terms weren’t disclosed.
Veranex recently acquired Medidee, which is based in Switzerland.
The newly acquired firms include:
- Devicia, a full-service partner offering clinical expertise
- Clarvin, a provider of strategic guidance in regulatory affairs and quality assurance
- Affiliated firms Kickfile, Lea Reg, and Limulus Bio
“This group of companies, led by Devicia and Clarvin, shares the same goal as Veranex: working with our clients to achieve and accelerate MedTech innovation,” said Veranex CEO David Dockhorn in a statement. “Devicia, Clarvin, and their affiliate companies all focus exclusively on medical devices and IVD, providing strategic guidance and informed execution across a number of areas, including clinical trial, medical writing, regulatory strategies, toxicology assessments, designated local representation, and system technologies that bolster Veranex’s full-service MedTech capabilities and solutions.”
Other backers of Veranex include Accelmed and Lauxera Capital Partners.
Veranex made six acquisitions in its first full year of operations.
Raleigh product development company Veranex lands two strategic partnerships
Raleigh firm partners with global investor to provide ‘soup-to-nuts’ medtech services
